Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f223fd81a50a52cd7d8328f186ea53d7 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d79a3a2626f7047bcb98a9be3a334498 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_577a1f046c996b8729b355afb4f68ab3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8090a5ea39f9b1b1658845081b6952ab http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_03aeb128ec45793f8fab199ef5217884 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_01963ea2054e4b8ead1593152f0b583d |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q2600-16 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6858 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-4703 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-18 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6827 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-6886 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-47 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-18 |
filingDate |
1997-01-06-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0d5a7cd9d14ad7f9d4f6819719098d27 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec458c9f45307f0b8887ab8b305b7bda http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_990e74d346d91ba0fa0bd1dbd3cfc6cd http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_03bae83ee3ee56a2e95d71c10dcbbce8 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5305bfed2bb4f362a70d513617b96376 |
publicationDate |
1997-07-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
WO-9724974-A2 |
titleOfInvention |
Compositions and methods for diagnosis of mutation in the von hippel-lindau tumor suppressor gene |
abstract |
The instant invention relates to methods and products for the diagnosis of mutations in the von Hippel-Lindau tumor suppressor gene. More specifically, the products are DNA oligonucleotides for use in amplifying and sequencing genomic DNA and kits including these oligonucleotides. The method of the invention relates to a hierarchical system for cost-effective diagnosis of von Hippel-Lindau tumor suppressor disease-associated mutations. |
isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6653107-B2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1307595-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1307595-A4 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6265152-B1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9916910-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-6830887-B2 |
priorityDate |
1996-01-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |